Home » Bristol-Myers to Sell Remaining Bufferin, Excedrin Assets
Bristol-Myers to Sell Remaining Bufferin, Excedrin Assets
Bristol-Myers Squibb Co. agreed to sell its Bufferin and Excedrin brands in Japan, Asia (excluding China and Taiwan) and certain Oceanic countries to Japan’s Lion Corp. for about $250 million.
CNNMoney
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May